Your browser doesn't support javascript.
loading
Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells.
Wang, Xin-Yi; Sun, Gui-Bin; Wang, Ya-Jing; Yan, Fang.
Affiliation
  • Wang XY; Department of Pharmaceutical Analysis, School of pharmacology, China Pharmaceutical University.
  • Sun GB; Nanjing Syrois Pharmaceutical Co., Ltd.
  • Wang YJ; Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University.
  • Yan F; Department of Pharmaceutical Analysis, School of pharmacology, China Pharmaceutical University.
Biol Pharm Bull ; 43(10): 1526-1533, 2020.
Article in En | MEDLINE | ID: mdl-32999163

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Genes, abl / Emodin / Drug Resistance, Neoplasm / STAT5 Transcription Factor / Imatinib Mesylate Limits: Humans Language: En Journal: Biol Pharm Bull Journal subject: BIOQUIMICA / FARMACOLOGIA Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Genes, abl / Emodin / Drug Resistance, Neoplasm / STAT5 Transcription Factor / Imatinib Mesylate Limits: Humans Language: En Journal: Biol Pharm Bull Journal subject: BIOQUIMICA / FARMACOLOGIA Year: 2020 Type: Article